KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Feb 27, 2026 >>  ABB India 6074.3  [ -0.81% ]  ACC 1592.55  [ -1.28% ]  Ambuja Cements 500.3  [ -2.32% ]  Asian Paints 2376.25  [ -0.78% ]  Axis Bank 1383.85  [ -0.78% ]  Bajaj Auto 9968.95  [ -1.38% ]  Bank of Baroda 321.85  [ -0.82% ]  Bharti Airtel 1879.75  [ -2.53% ]  Bharat Heavy 264.85  [ 0.00% ]  Bharat Petroleum 385.7  [ -0.05% ]  Britannia Industries 5994.25  [ -2.33% ]  Cipla 1347.65  [ -0.75% ]  Coal India 430.7  [ -0.68% ]  Colgate Palm 2253.6  [ -1.82% ]  Dabur India 518.55  [ -1.09% ]  DLF 604.15  [ -1.10% ]  Dr. Reddy's Lab. 1287.2  [ -2.40% ]  GAIL (India) 169.75  [ -0.12% ]  Grasim Industries 2800.1  [ -2.16% ]  HCL Technologies 1390.2  [ 1.22% ]  HDFC Bank 887.4  [ -1.27% ]  Hero MotoCorp 5709.6  [ -1.33% ]  Hindustan Unilever 2338.25  [ -1.90% ]  Hindalco Industries 925.95  [ -1.60% ]  ICICI Bank 1379  [ -1.85% ]  Indian Hotels Co. 667.3  [ -2.03% ]  IndusInd Bank 959  [ -0.57% ]  Infosys 1299.95  [ 0.82% ]  ITC 313.6  [ -1.45% ]  Jindal Steel 1244.65  [ -1.27% ]  Kotak Mahindra Bank 415.3  [ -2.18% ]  L&T 4280.55  [ -0.12% ]  Lupin 2301.35  [ -0.94% ]  Mahi. & Mahi 3399.9  [ -2.42% ]  Maruti Suzuki India 14869.55  [ -2.26% ]  MTNL 29.67  [ -1.69% ]  Nestle India 1291.45  [ -2.02% ]  NIIT 71.21  [ -1.18% ]  NMDC 81.8  [ -0.96% ]  NTPC 381.85  [ 0.00% ]  ONGC 279.9  [ -0.09% ]  Punj. NationlBak 129.3  [ -0.88% ]  Power Grid Corpn. 298.75  [ -1.57% ]  Reliance Industries 1394.3  [ -0.79% ]  SBI 1202  [ -0.60% ]  Vedanta 718.45  [ -2.56% ]  Shipping Corpn. 263.6  [ -1.70% ]  Sun Pharmaceutical 1738.1  [ -2.61% ]  Tata Chemicals 717.1  [ 0.13% ]  Tata Consumer Produc 1142.3  [ -1.47% ]  Tata Motors Passenge 383.15  [ -2.17% ]  Tata Steel 212.35  [ -1.46% ]  Tata Power Co. 377.35  [ -0.71% ]  Tata Consult. Serv. 2636.4  [ -0.43% ]  Tech Mahindra 1357.25  [ -0.33% ]  UltraTech Cement 12680.25  [ -1.96% ]  United Spirits 1383.2  [ -0.45% ]  Wipro 200.9  [ -0.05% ]  Zee Entertainment 87.47  [ 0.06% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

NIDAN LABORATORIES AND HEALTHCARE LTD.

27 February 2026 | 12:00

Industry >> Hospitals & Medical Services

Select Another Company

ISIN No INE0J6L01013 BSE Code / NSE Code / Book Value (Rs.) 50.08 Face Value 10.00
Bookclosure 27/09/2024 52Week High 25 EPS 1.42 P/E 11.32
Market Cap. 22.38 Cr. 52Week Low 15 P/BV / Div Yield (%) 0.32 / 0.00 Market Lot 1,000.00
Security Type Other

ACCOUNTING POLICY

You can view the entire text of Accounting Policy of the company for the latest year.
Year End :2025-03 

Note 2: Material Accounting Policies:

(a) Use of Estimates:

The preparation of financial statements in conformity with Indian GAAP requires management to make judgments,
estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
liabilities on the date of financial statements and the reported amounts of revenue and expenses during the reported
period. Although these estimates are based on management’s best knowledge of current events and actions, uncertainty
about these assumptions and estimates could result in the outcomes requiring a material adjustment to the carrying
amounts of assets or liabilities in future periods.

(b) Revenue Recognition:

The Company’s revenue is primarily generated from business of running laboratories for carrying out pathological
investigations of various branches of bio-chemistry, and other pathological and radiological investigations for customers
through various arrangements.

Revenue is measured based on the consideration specified in a contract with a customer. Revenue is recognised
at a point in time when the Company satisfies performance obligations by transferring the promised services to its
customers. Generally, each test represents a separate performance obligation for which revenue is recognised when
the test report is generated i.e when the performance obligation is satisfied.

Revenue towards satisfaction of performance obligation is measured at the amount of transaction price (net of variable
consideration) allocated to that performance obligation. The transaction price of services rendered is net of variable
consideration on account of discounts and schemes offered to the customers by the Company

For allocating the transaction price, the Company has measured the revenue in respect of each performance obligation
of a contract at its relative standalone selling price net of discounts. The price that is regularly charged for a test when
registered separately is the best evidence of its standalone selling price.

Interest Income:

Interest income is recognized on a time proportion basis taking into account the amount outstanding and the rate
applicable.

(c) Property, Plant and Equipment:

Property, plant and equipment are stated at cost of acquisition or construction less accumulated depreciation and
any accumulated impairment losses. The cost of Plant, Property & Equipment comprises of its purchase price, non¬
refundable taxes & levies, freight and other incidental expenses related to the acquisition and installation of the
respective assets. Borrowing cost attributable to financing of acquisition or construction of the qualifying Property,
Plant and Equipment is capitalised to respective assets when the time taken to put the assets to use is substantial

When major items of property, plant and equipment have different useful lives, they are accounted for as separate
items of property, plant and equipment. The cost of replacement of any property, plant and equipment is recognised in
the carrying amount of the item if it is probable that the future economic benefit associated with the item will flow to the
Company and its cost can be measured reliably

Capital work-in-progress comprises cost of Property, Plant and Equipment those are not yet installed and ready for
their intended use at the Balance sheet date.

d) The cost and related accumulated depreciated are eliminated from the financial statements upon sale or retirement of
the asset and the resultant gains or losses are recognized in the Statement of Profit and Loss. Assets to be disposed
of are reported at the lower of the carrying value or net realizable value;

e) Depreciation is provided on written down value basis based on life assigned to each asset in accordance with Schedule
ll of the Companies Act, 2013.

(d) Inventories:

Inventories are valued at lower of cost and net realizable value. Net realizable value is the estimated selling price in the
ordinary course of business, less estimated costs of completion and estimated costs necessary to make the sale.

The cost is determined as under in separate conditions:

i) Raw material and stores and Spares on FIFO basis.

ii) Work in Progress on material cost and appropriate share of overheads in bringing the inventory in present location
and condition.

iii) Finished Goods on material cost and overheads in bringing the inventory in present location and condition.

(e) Accounting for Taxes on Income:

Tax expenses comprises of current and deferred tax. Current income tax is measured at the amount expected to be
paid to the tax authorities in accordance with the Income tax Act, 1961.

Deferred Tax is recognized on timing difference being the difference between taxable income and accounting income
that originate in one period and are capable of reversal in one or more subsequent periods. Deferred Tax Assets arising
from timing differences are recognized to the extent there is a reasonable certainty that the assets can be realized in
future.

(f) Borrowing Cost:

Borrowing costs directly attributable to the acquisition, construction or production of an asset that necessarily takes a
substantial period of time to get ready for its intended use or sale are capitalized as part of the cost of the respective
asset. All other borrowing costs are expensed in the period they occur.

(g) Segment Reporting:

There is no segment reporting.

(h) Earnings per share:

Basic earnings per share is computed by dividing the net profit for the period attributable to equity shareholders by the
weighted average number of equity shares outstanding during the period. Diluted earnings per share is computed by
taking into account the aggregate of the weighted average number of equity shares outstanding during the period and
the weighted average number of equity shares which would be issued on conversion of all the dilutive potential equity
shares into equity shares.

(i) Foreign currency transactions:

No foreign currency transactions.

(j) Intangible assets:

Intangible Assets are stated at cost less accumulated amount of amortization.

(k) Amortization:

Intangible assets are amortized over their estimated useful lives from the date they are available for use.

(l) Impairment of Assets:

At each balance sheet date an assessment is made whether any indication exists that an asset has been impaired. If
any such indication exists, an impairment loss i.e., the amount by which the carrying amount of an asset exceeds its
recoverable amount is provided in the books of account.

(m) Cash and cash equivalents:

Cash comprises of cash on hand and demand deposit with banks other than under lien. Cash equivalents are short term,
highly liquid investments that are readily convertible into known amount of cash and which are subject to insignificant
risk of change in value.